Utah Trials Autonomous AI Medical System for Diagnostics, Prescriptions
Utah has initiated a pilot program for an artificial intelligence system capable of conducting medical examinations and issuing prescriptions without direct human physician oversight.
Utah has launched a pilot programme for a novel artificial intelligence (AI) system designed to autonomously manage specific medical consultations. The programme allows the AI, developed by the company DiagnosUs, to perform patient examinations and issue prescriptions. This process occurs without immediate human physician intervention.
The system targets a range of common conditions. These include urinary tract infections (UTIs) and contraception needs. DiagnosUs, the firm behind the technology, reports an accuracy rate for the AI that surpasses that of human doctors. Data provided by the company indicates a 98.6% accuracy in diagnosing certain conditions. This figure reportedly exceeds the average human diagnostic accuracy of 92%.
The AI functions through a chat-based interface. Patients interact with the system by answering a series of questions. The AI then analyses these responses to form a diagnosis and recommend a treatment plan. If a prescription is deemed necessary, the system can electronically submit it to a pharmacy.
Regulators in Utah approved this pilot under specific conditions. Oversight remains a critical component, though it is not direct in every interaction. Human physicians review a percentage of the AI's consultations retrospectively. This ensures adherence to medical standards and identifies potential areas for system improvement. The programme operates within a regulatory sandbox, a controlled environment for testing innovative technologies.
The move represents a significant step towards autonomous AI applications in healthcare. Proponents suggest such systems could improve access to care, particularly in underserved areas. Critics raise concerns regarding accountability and the potential for diagnostic errors. The long-term implications for healthcare delivery models remain a subject of ongoing analysis.
This pilot programme will continue for a defined period. Its success will be evaluated based on patient outcomes, system accuracy, and operational efficiency. The broader integration of autonomous AI into medical practice hinges on these findings. What metrics will ultimately define the boundaries of medical autonomy for artificial intelligence?
More from The Singularity Times
- Chinese AI Labs Anchor Recursive Self-Improvement to Industrial Policy23 Oct 2026 · 16:31 UTC
- Jack Clark Warns IMF That Technological Singularity Is Underway23 Oct 2026 · 16:31 UTC
- AI Infrastructure Buildout Clashes With Grid Interconnection Delays23 Oct 2026 · 16:31 UTC
- Token Throughput Disparity Emerges as Core Metric in US-China AI Rivalry23 Oct 2026 · 16:31 UTC
- Honolulu Civil Beat Restricts Generative AI to Back-Office Data Tasks23 Oct 2026 · 16:31 UTC